ClinVar Miner

Submissions for variant NM_000540.2(RYR1):c.4038C>A (p.Asn1346Lys) (rs777049924)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics RCV000657029 SCV000344618 uncertain significance not provided 2016-08-24 criteria provided, single submitter clinical testing
GeneDx RCV000657029 SCV000589419 uncertain significance not provided 2018-04-10 criteria provided, single submitter clinical testing The N1346K variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The N1346K variant is observed in 14/70242 (0.02%) alleles from individuals of European background (Lek et al., 2016). The N1346K variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. However, in-silico analyses, including protein predictors and evolutionary conservation, support that this variant does not alter protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant.
Illumina Clinical Services Laboratory,Illumina RCV000313458 SCV000412092 uncertain significance Neuromuscular disease, congenital, with uniform type 1 fiber 2016-06-14 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000370505 SCV000412093 uncertain significance Myopathy, Central Core 2016-06-14 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000273611 SCV000412094 uncertain significance Malignant hyperthermia susceptibility 2016-06-14 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000331017 SCV000412095 uncertain significance Multiminicore Disease 2016-06-14 criteria provided, single submitter clinical testing
Invitae RCV000655552 SCV000777483 uncertain significance RYR1-Related Disorders 2018-10-11 criteria provided, single submitter clinical testing This sequence change replaces asparagine with lysine at codon 1346 of the RYR1 protein (p.Asn1346Lys). The asparagine residue is weakly conserved and there is a moderate physicochemical difference between asparagine and lysine. While this variant is not present in population databases, the frequency information is unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has not been reported in the literature in individuals with RYR1-related disease. ClinVar contains an entry for this variant (Variation ID: 290117). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
PreventionGenetics RCV000657029 SCV000852596 uncertain significance not provided 2017-05-15 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.